Electrophysiological and clinical desensitization to apomorphine administration in parkinsonian patients undergoing stereotaxic neurosurgery

Experimental Neurology

Volumn 156, Issue 1, 1999, Pages 209-213

  Stefani, A ^a,b   Mazzone, P ^c   Bassi, A ^a   Bernardi, G ^a,b   Altibrandi, M G ^c   Peppe, A ^a   Pierantozzi, M ^a   Stanzione, P ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CTO Hospital ASL Roma C   (Italy)

Author keywords

Apomophine; Basal ganglia; Desensitization; Dopamine; Extracellular recordings; Human; Parkinson's disease

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CASE REPORT; DESENSITIZATION; DRUG RESPONSE; GLOBUS PALLIDUS; HUMAN; HYPOKINESIA; NEUROSURGERY; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STEREOTAXIC SURGERY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033061942     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6990     Document Type: Article

References (23)

1. Antonini R., Vontobel P., Psylla M., Gunther I., Maguire P. R., Missimer J., Leenders K. L. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch. Neurol. 52:1995;1183-1190.
2. Benabid A. L., Pollak P., Gervason C. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 337:1991;403-406.
3. Bravi D., Mouradian M. M., Roberts J. W., Davis T. L., Sohn Y. H., Chase T. N. Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms. Ann. Neurol. 36:1994;27-31.
4. Colosimo C., Merello M., Hughes A. J., Sieradzan K., Lees A. J. The motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: Implications for the pathogenesis of the on-off phenomenon. J. Neurol. Neurosurg. Psychiatry. 61:1996;634-637.
5. DeLong M. R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
6. Fabbrini G., Juncos J., Mouradian M. M. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann. Neurol. 21:1987;370-376.
7. Fahn S., Elton R. L. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease. 1987;Macmillan, Florham Park. p. 153.
8. Filion M., Tremblay L., Bedard P. J. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;152-161.
9. Grandas F. Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's disease. Neurology. 42:1992;1287-1290.
10. Greenamyre J. T. Pharmacological pallidotomy with glutamate antagonists. Ann. Neurol. 39:1996;557-558.
11. Hardie R. J., Lees A. J., Stern G. M. On-off fluctuations in Parkinson's disease: A clinical and neuropharmacological study. Brain. 107:1984;487-506.
12. Hutchinson W. D., Levy R., Dostrovsky O., Lozano A. M., Lang A. E. Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann. Neurol. 42:1997;767-775.
13. Maggio R., Barbier P., Corsini G. U. Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response. J. Neural Transm. 45:1995;133-136.
14. Marsden C. D. On-off phenomena in Parkinson's disease. Rinne UK, Klinger M, Stamm G. Parkinson's disease: current progress, problems and management. 1980;241-254 Elsevier/North Holland-Biochemical Press, Amsterdam.
15. Marsden C. D., Parkers J. D., Quinn N. Fluctuations in disability in Parkinson's disease: Clinical aspects. Marsden C. D., Fann S. Movement Disorders. 1982;96-122 Butterworth Scientific, New York.
16. Nutt J. G., Carter J. H., Woodward W. R. Long duration response to levodopa. Neurology. 45:1995;1613-1616.
17. Nutt J. G., Carter J. H., Van Houten L., Woodward W. R. Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann. Neurol. 42:1997;349-355.
18. Rusk G. D., Siemers E. R. Diurnal variation in motor ability in Parkinson's disease. Ann. Neurol. 34:1993;266-267.
19. Stefani A., Stanzione P, Bassi A., Mazzone P., Vangelista T., Bernardi G. Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: Clinical score and globus pallidus activity. J. Neural Transm. 104:1997;895-904.
20. Sweet R. D., Lee J. E., Spiegel H. E., McDowell F. H. Enhanced response to low doses of levodopa after withdrawal from chronic treatment. Neurology. 22:1976;520-525.
21. Torstenson R., Hartvig H., Langstrom B., Westerberg G., Tedroff J. Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease. Ann. Neurol. 41:1997;337-340.
22. Verhagen Metman L., Locatelli E. R., Bravi D., Mouradian M. M., Chase T. N. Apomorphine response in parkinson's disease and the pathogenesis of motor complications. Neurology. 48:1997;369-372.
23. Weiner W. J., Kller W. C., Perlik S., Nausieda P. A., Klawans H. L. Drug holiday and management of Parkinson's disease. Neurology. 30:1980;1257-1261.